Cargando…
CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases
The ability of cullin 4A (CUL4A), a scaffold protein, to recruit a repertoire of substrate adaptors allows it to assemble into distinct E3 ligase complexes to mediate turnover of key regulatory proteins. In the past decade, a considerable wealth of information has been generated regarding its biolog...
Autores principales: | Sharma, Puneet, Nag, Alo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938054/ https://www.ncbi.nlm.nih.gov/pubmed/24522884 http://dx.doi.org/10.1098/rsob.130217 |
Ejemplares similares
-
The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies
por: Hannah, Jeffrey, et al.
Publicado: (2013) -
Targeted Ubiquitination and Degradation of G-Protein-Coupled Receptor Kinase 5 by the DDB1-CUL4 Ubiquitin Ligase Complex
por: Wu, Ziyan, et al.
Publicado: (2012) -
Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
por: Hu, Xiaoyan, et al.
Publicado: (2019) -
Cul4 ubiquitin ligase cofactor DCAF12 promotes neurotransmitter release and homeostatic plasticity
por: Patrón, Lilian A., et al.
Publicado: (2019) -
The ubiquitin ligase Cul5 regulates CD4(+) T cell fate choice and allergic inflammation
por: Kumar, Binod, et al.
Publicado: (2022)